Views & Analysis | Perspectives on pharma industry issues

Digital

AI is redefining decision-making in biopharma R&D

AI has kickstarted a new wave of innovation in biopharma R&D.

Patients

pharmaphorum podcast Episode 273, James Davis, PA Consulting

Deliver prevention at scale, PA Consulting’s James Davis

James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.

R&D

two healthcare professionals looking at chart

Sponsored

Decentralisation by design: Bringing the trial closer withou...

In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.

R&D

Board of Directors graphic over sunset across cityscape

Changing Faces: Board appointments, June and July 2026

Board appointments June/July brought together veterans from across the pharmaceutical industry, venture capital, healthcare technology, and academia

Patients

Two faced man's silhouette, one side blue, the other red, with faces in the background

In schizophrenia care, even the support system needs support

After a schizophrenia diagnosis, families must learn how to navigate treatment, respond to symptoms, and communicate effectively.

Views & Analysis

2018 Review pharma Alzheimer's CRISPR AI

2018 in review: Alzheimer’s falters while oncology shines

Going into 2018 you might have expected this to be the year of Alzheimer’s drugs, with several promising trials underway – but unfortunately the last 12 months have been marked by failure a

Views & Analysis

2018 in review: AI on the rise in digital pharma

Digital technology is playing an increasingly important role in healthcare, and in the pharma industry as it searches for ways to find new drugs, while cutting costs and reducing expensive

R&D

Biotech strategy and nanomedicine: the pharmaphorum podcast

For episode 5 of the pharmaphorum podcast Dominic Tyer met Blueberry Therapeutics’ CEO Dr John Ridden at The Wellcome Coll

Sales & Marketing

Recruitment concept graphic on beige background

Changing Faces: Agency, consultancy, and investor hires, Jun...

Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.

Sales & Marketing

Sponsored

Personalisation is the biggest lie brands keep telling

Pharma brands need to move beyond surface-level personalisation and focus on measurable impact.

Digital

AI is redefining decision-making in biopharma R&D

AI has kickstarted a new wave of innovation in biopharma R&D.

Digital

Sponsored

Technology solutions for smarter clinical trials: Inventus

In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum to discuss the company's journey & ethos

Market Access

What India can learn from Kinvard Bio

India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.

Market Access

The new commercialisation playbook: What BIO 2026 taught eme...

BIO International focused on how emerging biotech companies should approach their first product launch outside the United States, typically in Europe.